Synapsoft logo
AI Insights from Disclosures
Searching...
SAMIK PHARM. CO.,LTD. 014950
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
SAMIK PHARM. CO.,LTD. mainly engages in prescription drugs among finished pharmaceuticals, with synthetic pharmaceuticals as its main business by production material classification, while also operating a CMO business in parallel. The company develops and produces prescription drugs across various therapeutic areas, centering on treatments for the three major chronic diseases of hypertension, diabetes, and hyperlipidemia, as well as over-the-counter drugs such as motion sickness medicine, tonics for children with weak constitutions, and cold medicines, and conducts research on natural-product-derived new drugs, exploration of low-molecular new drug candidates, improved new drugs, and first-generic development.
Representative Director Lee Chunghwan
Founded July 23, 1980
Corporation Type KOSDAQ
Industry Classification Manufacture of synthetic drug and other finished medicaments
Corporate number 12011-0009755
Business number 122-81-13217
Phone Number 02-928-0661
Fax Number 02-927-7525
Website www.samik.co.kr
Company Address 13 Cheongan-ro, Bupyeong-gu, Incheon

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant